Cell, volume 181, issue 2, pages 271-280.e8

SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor

Markus Hoffmann
Hannah Kleine Weber
Simon Schroeder
Nadine Krüger
Tanja Herrler
Sandra Erichsen
Tobias S. Schiergens
Georg HERRLER
Nai-Huei Wu
Andreas Nitsche
Marcel A. Müller
Christian Drosten
Stefan Pöhlmann
Publication typeJournal Article
Publication date2020-04-01
Journal: Cell
Quartile SCImago
Q1
Quartile WOS
Q1
Impact factor64.5
ISSN00928674, 10974172
General Biochemistry, Genetics and Molecular Biology

Top-30

Citations by journals

50
100
150
200
250
300
350
Frontiers in Immunology
310 publications, 2.04%
Viruses
293 publications, 1.93%
International Journal of Molecular Sciences
290 publications, 1.91%
Scientific Reports
185 publications, 1.22%
Nature Communications
129 publications, 0.85%
Journal of Medical Virology
121 publications, 0.8%
Frontiers in Pharmacology
118 publications, 0.78%
Vaccines
114 publications, 0.75%
PLoS ONE
101 publications, 0.66%
Frontiers in Medicine
96 publications, 0.63%
Journal of Clinical Medicine
93 publications, 0.61%
Journal of Biomolecular Structure and Dynamics
92 publications, 0.61%
Frontiers in Microbiology
91 publications, 0.6%
Journal of Virology
87 publications, 0.57%
Cells
84 publications, 0.55%
Pathogens
78 publications, 0.51%
iScience
77 publications, 0.51%
Heliyon
75 publications, 0.49%
Cell
72 publications, 0.47%
Cureus
71 publications, 0.47%
mBio
68 publications, 0.45%
Frontiers in Cellular and Infection Microbiology
67 publications, 0.44%
PLoS Pathogens
66 publications, 0.43%
Molecules
66 publications, 0.43%
Biomedicines
62 publications, 0.41%
Cell Reports
62 publications, 0.41%
Proceedings of the National Academy of Sciences of the United States of America
62 publications, 0.41%
Biomedicine and Pharmacotherapy
60 publications, 0.39%
Signal Transduction and Targeted Therapy
58 publications, 0.38%
50
100
150
200
250
300
350

Citations by publishers

500
1000
1500
2000
2500
3000
Elsevier
2676 publications, 17.61%
Springer Nature
2176 publications, 14.32%
Cold Spring Harbor Laboratory
1781 publications, 11.72%
Multidisciplinary Digital Publishing Institute (MDPI)
1602 publications, 10.55%
Frontiers Media S.A.
1112 publications, 7.32%
Wiley
1019 publications, 6.71%
Taylor & Francis
357 publications, 2.35%
American Chemical Society (ACS)
316 publications, 2.08%
Oxford University Press
277 publications, 1.82%
Wolters Kluwer Health
257 publications, 1.69%
American Society for Microbiology
241 publications, 1.59%
Public Library of Science (PLoS)
196 publications, 1.29%
Bentham Science
155 publications, 1.02%
SAGE
148 publications, 0.97%
Baishideng Publishing Group
114 publications, 0.75%
American Association for the Advancement of Science (AAAS)
98 publications, 0.65%
Thieme
75 publications, 0.49%
Royal Society of Chemistry (RSC)
72 publications, 0.47%
BMJ
70 publications, 0.46%
Dove Medical Press
68 publications, 0.45%
American Physiological Society
68 publications, 0.45%
Hindawi Limited
64 publications, 0.42%
Proceedings of the National Academy of Sciences (PNAS)
62 publications, 0.41%
Future Medicine
50 publications, 0.33%
Mary Ann Liebert
46 publications, 0.3%
Spandidos Publications
41 publications, 0.27%
Cambridge University Press
40 publications, 0.26%
Portland Press
39 publications, 0.26%
American Society for Biochemistry and Molecular Biology
39 publications, 0.26%
500
1000
1500
2000
2500
3000
  • We do not take into account publications without a DOI.
  • Statistics recalculated only for publications connected to researchers, organizations and labs registered on the platform.
  • Statistics recalculated weekly.

Are you a researcher?

Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
Share
Cite this
GOST |
Cite this
GOST Copy
Hoffmann M. et al. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor // Cell. 2020. Vol. 181. No. 2. p. 271-280.e8.
GOST all authors (up to 50) Copy
Hoffmann M., Kleine Weber H., Schroeder S., Krüger N., Herrler T., Erichsen S., Schiergens T. S., HERRLER G., Wu N., Nitsche A., Müller M. A., Drosten C., Pöhlmann S. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor // Cell. 2020. Vol. 181. No. 2. p. 271-280.e8.
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.1016/j.cell.2020.02.052
UR - https://doi.org/10.1016/j.cell.2020.02.052
TI - SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
T2 - Cell
AU - Hoffmann, Markus
AU - Kleine Weber, Hannah
AU - Schroeder, Simon
AU - Krüger, Nadine
AU - Herrler, Tanja
AU - Erichsen, Sandra
AU - Schiergens, Tobias S.
AU - HERRLER, Georg
AU - Wu, Nai-Huei
AU - Nitsche, Andreas
AU - Müller, Marcel A.
AU - Drosten, Christian
AU - Pöhlmann, Stefan
PY - 2020
DA - 2020/04/01 00:00:00
PB - Elsevier
SP - 271-280.e8
IS - 2
VL - 181
PMID - 32142651
SN - 0092-8674
SN - 1097-4172
ER -
BibTex |
Cite this
BibTex Copy
@article{2020_Hoffmann,
author = {Markus Hoffmann and Hannah Kleine Weber and Simon Schroeder and Nadine Krüger and Tanja Herrler and Sandra Erichsen and Tobias S. Schiergens and Georg HERRLER and Nai-Huei Wu and Andreas Nitsche and Marcel A. Müller and Christian Drosten and Stefan Pöhlmann},
title = {SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor},
journal = {Cell},
year = {2020},
volume = {181},
publisher = {Elsevier},
month = {apr},
url = {https://doi.org/10.1016/j.cell.2020.02.052},
number = {2},
pages = {271--280.e8},
doi = {10.1016/j.cell.2020.02.052}
}
MLA
Cite this
MLA Copy
Hoffmann, Markus, et al. “SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor.” Cell, vol. 181, no. 2, Apr. 2020, pp. 271-280.e8. https://doi.org/10.1016/j.cell.2020.02.052.
Found error?